cas 2098215-73-5|| where to buy [4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methanamine

製品名:[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methanamine

IUPAC Name:1-{4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methanamine

: CAS番号：2098215-73-5; 分子式：C12H12F3N3; 純度：95%+

: カタログ番号：CM1017820; 分子量：255.24

包装単位	有効在庫	価格（USD）
CM1017820-100mg	in stock	Əǟĳ
CM1017820-250mg	in stock	ţǟŁ
CM1017820-10g	in stock	ţĳŁţ

問い合わせ: sales@chemenu.com

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2098215-73-5 regularly via the above email.

追記事項

Verification code*

refresh

製品詳細

: CAS番号:2098215-73-5; 分子式:C12H12F3N3; 融点:-; SMILESコード:NCC1=CC=C(C=C1)C2N(C)C=C(C(F)(F)F)N=2; 密度:

: カタログ番号:CM1017820; 分子量:255.24; 沸点:; MDL番号:; 保管方法:

Category Infos

: Fluorinated Compounds; Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.

Column Infos

: TNG348; Dose escalation is ongoing in the TNG348, a novel inhibitor of USP1 (ubiquitin-specific protease 1), phase 1/2 clinical trial evaluating the safety, pharmacokinetics, pharmacodynamics and efficacy of TNG348 as a single agent and in combination with olaparib, a PARP inhibitor, in patients with BRCA1/2 mutant and other HRD+ (homologous recombination deficient) cancers. The first patient dosed was announced in January 2024.Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products

394-59-2

154598-53-5

1868-00-4

21084-22-0

79756-81-3

1148050-30-9

184970-29-4

127852-28-2

762292-75-1

78573-45-2

251352-64-4

220227-29-2

50823-90-0

225920-05-8

56456-48-5

919054-04-9

157437-25-7

2006277-57-0

72768-97-9

1799733-46-2

651-70-7

402-45-9

126728-58-3

723286-98-4

144230-52-4

281652-10-6

1303974-56-2

496807-97-7

209971-49-3

166275-25-8

1394129-94-2

178312-47-5

1093751-02-0

889940-13-0

680-65-9

27607-77-8

1033805-26-3

40161-55-5

349-66-6

1341606-13-0

1001853-59-3

1039621-73-2

1052713-53-7

1067914-81-1

1067914-83-3

1067915-34-7

1117936-64-7

1159813-93-0

1187929-38-9

1191096-28-2

1196145-11-5

119895-68-0

1202076-02-5

1209780-71-1

1215071-12-7

1215071-16-1

1215071-19-4

1234616-26-2

1234616-37-5

1250444-03-1

1254104-06-7

1255663-89-8

1255666-48-8

1255666-86-4

1255667-06-1

1258638-82-2

1260852-42-3

126120-87-4

1263132-31-5

1263180-22-8

1263181-92-5

1523618-12-3

1303972-81-7

1303973-22-9

1303973-94-5

1303974-47-1

1334416-77-1

1359656-87-3

1363380-83-9

1363382-18-6

1363384-67-1

1365759-12-1

1407991-22-3

1407991-24-5

1408002-85-6

1408057-39-5

1408074-83-8

1408148-48-0

1419101-45-3

1425931-95-8

1434141-81-7

1523541-80-1

1523606-30-5

156046-05-8

1630906-35-2

1630906-58-9

17129-06-5

190903-71-0

203866-15-3

203866-17-5

215918-21-1

267875-65-0

33070-32-5

398156-38-2

460-37-7

531508-46-0

536747-87-2

647857-74-7

656-42-8

68119-31-3

70961-05-6

762240-99-3

849832-73-1

858121-94-5

915230-14-7

939398-48-8

1805892-28-7

1214361-12-2

230615-51-7

631909-42-7

957207-09-9

65686-77-3

872624-60-7

577742-69-9

1060801-56-0

1483-47-2

116640-12-1

1224599-55-6

1379686-14-2

296277-59-3

453-34-9

30984-28-2

1249101-79-8

504413-26-7

403660-48-0

647863-25-0

1344733-56-7

504413-35-8

358-23-6

6226-25-1

352-24-9

667-27-6

920-66-1

10444-89-0

349-82-6

836-35-1

84547-91-1

162401-59-4

1185033-39-9

17432-00-7

667437-45-8

343604-08-0

70627-18-8

380427-19-0

3792-04-9

2707-23-5

307557-56-8

667413-01-6

114467-21-9

24568-13-6

56915-87-8

5458-14-0

870-51-9

834913-89-2

57965-21-6

404-26-2

32707-89-4

349-75-7

346-06-5

99727-20-5

349-95-1

26198-21-0

1992-09-2

202134-57-4

113242-93-6

375-01-9

368-63-8

113048-69-4

276861-64-4

446-63-9

83494-26-2

453-35-0

85014-17-1

85014-08-0

138624-99-4

1188228-02-5

1354930-06-5

126485-55-0

2058331-75-0

1262412-64-5

1152029-16-7

1038262-63-3

852392-18-8

172490-05-0

3832-24-4

1429913-43-8

1219606-48-0

98-17-9

828-27-3

50824-04-9

112250-01-8

6294-93-5

444-30-4

827-99-6

81107-97-3

320-49-0

141483-15-0

779-88-4

32858-93-8

1000339-94-5

402-05-1

116640-11-0

690264-39-2

142167-36-0

1025718-84-6

1214332-23-6

1548-61-4

731002-53-2

55601-21-3

1638767-86-8

170015-96-0

1183107-04-1

2044706-96-7

1156491-11-0

921599-70-4

470703-82-3

1489096-86-7

57946-61-9

37885-07-7

64321-95-5

1544-85-0

187217-99-8

132877-27-1

15959-93-0

215798-14-4

1257855-77-8

13349-91-2

1434141-99-7

1000931-80-5

1039741-54-2

1215071-17-2

956477-67-1